| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
2-Isopentenyl)-adenosine on a Cell Line Derived from Circulating Leukocytes of a Patient with Chronic Myelogenous Leukemia1
Department of Biochemistry, McMaster University, Hamilton, Ontario, Canada
N6-(
2-Isopentenyl)adenosine (i6 Ado) at a concentration of 3 µM inhibits the growth of a line of cells derived from the circulating leukocytes of a patient with myelogenous leukemia, Roswell Park Memorial Institute line 6410. No alteration in the alkaline phosphatase activity of these cells is observed under these conditions.
i6 Ado is a component of 6410 cell tRNA but could not be detected as a nucleoside free in the cells or culture medium. The tRNA of cells cultured in the presence of i6 Ado contains a normal complement of
2-isopentenyl groups.
Line 6410 cells contain an enzyme activity that converts i6Ado to the corresponding base, which is much less toxic to these cells.
1 This work was supported by a grant from the National Cancer Institute of Canada and by Grant MT-2738 from the Medical Research Council of Canada.
2 Research Fellow of the National Cancer Institute of Canada.
Received 10/26/71. Accepted 4/18/72.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |